Usefulness of 3D Digital Reconstruction in the Imaging Diagnosis of Pancreatic Tumors

• Sponsor: Hospital Universitario Virgen de la Arrixaca (Other)
• Overall Status: Recruiting
• CT.gov ID: NCT04783844
• Collaborator: (none)
• Enrollment: 60
• Location: 1
• Anticipated Duration (Months): 19
• Patients Per Site Per Month: 3.2

Study Details

Study Description

Brief Summary

Reconstruction using 3D virtual models has brought about a revolution in diagnostic imaging and its use is increasingly widespread. The objective of this work is to determine the precision of the 3D model when establishing the characteristics of tumors and their relationship with other anatomical structures.

Condition or Disease	Intervention/Treatment	Phase
Pancreas Neoplasm	Diagnostic Test: Virtual modelization.

Study Design

• Study Type: Observational
• Anticipated Enrollment: 60 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: Usefulness of 3D Digital Reconstruction in the Imaging Diagnosis of Pancreatic Tumors
• Actual Study Start Date: Oct 1, 2019
• Anticipated Primary Completion Date: May 1, 2021
• Anticipated Study Completion Date: May 1, 2021

Outcome Measures

Primary Outcome Measures

1. Accuracy [1 day]

   To evaluate the correlation between the findings in the virtual model and in the CT.

Eligibility Criteria

Criteria

• Ages Eligible for Study: N/A and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Patients with suspected pancreatic tumor.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	David Ferreras	Murcia		Spain	30120

Sponsors and Collaborators

• Hospital Universitario Virgen de la Arrixaca

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: David Ferreras, Principal Investigator, Hospital Universitario Virgen de la Arrixaca
• ClinicalTrials.gov Identifier: NCT04783844
• Other Study ID Numbers: Virtual pancreas
• First Posted: Mar 5, 2021
• Last Update Posted: Mar 9, 2021
• Last Verified: Mar 1, 2021

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by David Ferreras, Principal Investigator, Hospital Universitario Virgen de la Arrixaca: 3D virtual model
• Additional relevant MeSH terms: Pancreatic Neoplasms

Study Results

No Results Posted as of Mar 9, 2021